Bristol Myers Squibb · Pharmaceuticals & biotech
AI across biologics and cell-therapy production at BMS Devens
a 42% reduction in New Product Introduction (NPI) time
Case study · Pharmaceuticals & biotech
Fast-changing, rising demand for biologics required faster technology transfer and more reliable supply.
Independently assessed This result was assessed or published by a party other than the manufacturer or its vendor (a World Economic Forum Lighthouse assessment, a government or institute report, or a peer-reviewed paper).
Fast-changing, rising demand for biologics required faster technology transfer and more reliable supply.
Janssen connected R&D, internal and external manufacturing and deployed AI-powered advanced process control and analytics for deviation root causes.
Percent change as reported by the source; hover for the exact wording
AI-powered process control for biologics manufacturing.
Analytics platform for deviation root-cause identification.
Outcomes as reported by the source. We do not adjust, combine or extrapolate reported figures.
Bristol Myers Squibb · Pharmaceuticals & biotech
a 42% reduction in New Product Introduction (NPI) time
Argos USA · Cement, glass & building materials
Demonstrated 28% reduction in energy consumption while maintaining product quality and improving throughput at the cement plant.
Georgia-Pacific · Paper & packaging
Demonstrated 40% reduction in defoamer usage, improving environmental impact of brownstock washing.
Novelis · Metals & fabrication
53% Scope 3 emissions
Put AI to work
Genvo, our implementation partner, works with manufacturers to pick the right first project, connect the systems you already run and put AI agents and tools into daily use, with people approving what goes out.
Assessments and consultations are provided by Genvo. How our partnership works.